Grants>Blood Disorders

Histiocytosis Association 2013 Request for Research Proposals

Conquering the Histiocytic Disorders

The Histiocytosis Association funded more than $300,000 in scientific research in 2012. 

Application for 2013 funding will be accepted online from May 15 to July 31, 2013.

Grant Award Amount: up to $50,000 USD each

Grant Award Date: December 2013

A Rare Community

The Histiocytosis Association is a global nonprofit organization dedicated to addressing the unique needs of
patients and families dealing with the effects of histiocytic disorders while leading the search for a cure. It is the
only organization of its kind, connecting the patient and medical communities to:

• Grow and share knowledge of histiocytic disorders,

• Provide critical emotional and educational support to patients and families, and

• Identify and fund key research initiatives that will lead to a world free of histiocytic disorders.

Funding the Path to a Cure

Proposals for scientific research are being accepted for studies into the causes, mechanisms, and improved
means of treatment for histiocytic disorders. Proposals will be evaluated on the basis of science, feasibility, and
relevance. All proposals should address one or more of the histiocytic disorders; below are areas of particular
interest; however, all relevant areas of interest will be considered.

• Mechanisms of disease pathogenesis

• Biology (maturation, migration and immune function) of dendritic cells, macrophages and/or

• lymphocytes in disease pathogenesis

• Derangements of cytokine production or function

• CNS pathology

• Neuropsychiatric consequences

• Studies of rare forms -- Juvenile xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman disease

•Studies of histiocytic disorders in adults

• Discovery of new disease markers

• Startup support for pilot studies/clinical trials

Research Grant Applications will be reviewed and evaluated by the Histiocyte Society Scientific Committee for relevance, scientific impact and feasibility. The Histiocytosis Association receives the composite score from this review, and the grant applications are then ranked for funding based upon programmatic needs and the availability of funds in each grant application cycle.

For questions regarding Research grants, please contact grants@histio.org.

Children’s Leukemia Research Association Research Grant Program

Each year, CLRA's Medical Advisory Committee, consisting of prominent internationally known and respected hematologists, reviews submitted research proposals from doctors nationwide. 

Using your contributions, we fund research grants for doctors who are conducting the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.

The objectives of this committee are to direct the funds of the Association into the most promising projects, and where funding would not duplicate other funding sources.

With your help, we are getting closer every day! Because of the support of friends like you, the scientific community is making incredible strides in developing chemotherapy regimens that are extending the lives of leukemia patients. Not everyone under treatment goes into remission but our research grants are funding the examinations into why this is so, and how we can continue to combat leukemia.

How the CLRA Research Grant Program Works

Any doctor at the Ph.D. or MD level who is involved in research towards finding the causes and cure for leukemia may apply.

Simply complete online form and print, or call or write to us for one.

Please submit an original and three copies of your application prior to June 30 of each year.  It is then reviewed by our Medical Advisory Committee. A decision is made by the following calendar year.

In order that we may fund as many projects as possible, grants are limited to a maximum of $30,000 each, subject to availability of funds.

CLRA
585 Stewart Avenue
Suite 18
Garden City, NY 11530

Tel:  516-222-1944
Fax: 516-222-0457

info@childrensleukemia.org

Request for Application: Cutaneous Lymphoma Foundation’s CLARIONS Research Awards Program

The signature funding initiative of the Research Awards Program (RAP), is the CLARIONS Grant Program, which stands for Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions.  This research grant program supports investigators interested in conducting innovative cutaneous lymphoma research.   These grants will help uncover causes and improve the treatment and quality of life for patients. Discovering new avenues for better therapies and, one day, a cure for cutaneous lymphoma are key goals of this program.

Research Funding Priorities

Eligibility and Requirements

Investigators at all levels, from clinical and post-doctoral fellows to established investigators, are eligible to receive
awards. Medical students and graduate students are not eligible. Non-U.S. investigators are eligible and the research funded by the RAP can be conducted at non-U.S. institutions. Investigators must be members of an established and recognized academic institution. All research projects involving human subjects must receive IRB approval.

Award Amounts

Each year the CLF will provide two $25,000 awards, renewable for 1 year contingent upon approval by the CLF
Board of Directors based upon the CLF Scientific Review Board’s review and recommendation.

A small indirect cost amount between $1,000-$2,000 is allowable.

The CLF’s RAP seeks to fund innovative research in all areas of cutaneous lymphomas with particular interest in:

-- Etiology and risk factors of cutaneous lymphomas.

-- Measures of disease impact on individuals and populations affected by cutaneous lymphomas.

-- Translating discoveries into diagnostic and therapeutic advances in cutaneous lymphomas.

-- Optimizing therapies for cutaneous lymphomas.

-- Improving quality of life for individuals with cutaneous lymphomas

2013 Calendar of Award Events

January 31 -  Public announcement of Request for Application (RFA)

July 31 -  Application deadline

August - October - Scientific Review Board review

November - Recipients notified of award

December - Grant awards announced at ASH meeting

January, 2014 - Disbursement of Award and beginning of new award cycle

Cutaneous Lymphoma Foundation
PO Box 374
Birmingham, MI 48012-0374

Telephone: 248-644-9014

Fax: 248-644-9014